Status:
UNKNOWN
Umbilical Cord Mesenchymal Stem Cells Infusion for Ulcerative Colitis
Lead Sponsor:
Qingdao University
Conditions:
Ulcerative Colitis
Mesenchymal Stem Cells
Eligibility:
All Genders
18-70 years
Phase:
PHASE1
PHASE2
Brief Summary
The purpose of this study is to determine whether umbilical cord Mesenchymal Stem Cells of treatment for ulcerative colitis is safe and effective.
Detailed Description
Ulcerative colitis is characterized as chronic and nonspecific inflammation of gastroenteritis tract．Nowadays，etiology and pathogenesis of UC have been unclear．Recent basic research has been revealed ...
Eligibility Criteria
Inclusion
- Male or female, 18 years of age or older.
- Ulcerative colitis described according to usual criteria.
- Refractoriness Ulcerative colitis or unefficient by using other therapy
- Signed informed consent form.
Exclusion
- History of neoplasm or hematological disease
- Uncontrolled high blood pressure (\>180/110)
- Severe cardiac insufficiency (New York Heart Association \[NYHA\] IV) or ejection fraction\<30%
- Malignant ventricular arrythmia
- Deep venous thrombosis during the last 3 months
- Active bacterial infection
- Body mass index \> 35 Kg/m2
- Stroke or myocardial infarction during the last 3 months
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2012
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01221428
Start Date
September 1 2010
End Date
December 1 2012
Last Update
October 15 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stem Cell Research Center of Medical School Hospital of Qingdao University
Qingdao, Shandong, China, 266003